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or patients with advanced heart failure, there are an increasing number of therapies, especially in the form of mechanical circulatory support (MCS). There are several classes of MCS devices, distinguished by hemodynamic characteristics of the pump, the sites from which blood is withdrawn and returned, the size of catheters and/or cannulas used, whether the insertion technique is percutaneous or surgical, and whether or not a gas exchange unit is used. Some devices are for short-term use, whereas others can be used for the duration of a patient's life. These characteristics contribute to determining the ease of deployment, ease of patient management while on the device, and overall safety profile, as reviewed recently in detail (1) This review aims to provide a concise overview of advanced hemodynamic principles, including the basics of ventricular mechanics, ventricular-vascular coupling, and myocardial energetics (see [8] [9] [10] for detailed descriptions). We will then review how these principles can be applied to better understand the hemodynamic effects of MCS. The ESPVR shifts with changes in ventricular contractility ( Figure 1C ) (8, 12) . Increases and decreases in contractility are associated with leftward and rightward shifts of the ESPVR, respectively, which are generally manifested as changes in Ees. In reality, Vo can also shift with changes in contractility.
FUNDAMENTALS OF LEFT VENTRICULAR MECHANICS
It is therefore necessary to account for changes of both Ees and Vo when using ESPVR to index contractility. This can be achieved through use of an index that integrates changes in both Ees and Vo, such as V 120 , the volume at which the ESPVR reaches 120 mm Hg: V 120 ¼ 120/Ees þ Vo. Higher values of V 120 are associated with decreased contractility and vice versa.
The EDPVR is nonlinear and defines the passive diastolic properties of the ventricle (Figure 2A ). This nonlinearity introduces complexity when indexing diastolic properties, specifically diastolic stiffness.
Stiffness is the change in pressure for a given change in volume (dP/dV). Accordingly, diastolic stiffness varies with filling pressure, increasing as EDP increases, even in normal hearts. Some reports incorrectly quantify stiffness by the ratio of EDP to EDV (P/V), which also varies with filling pressure (Figure 2A) . From an engineering perspective, diastolic material properties of the heart can be more appropriately indexed by its dimensionless stiffness constant, defined as (dP/dV)/(P/V) (8) Another index of diastolic properties is ventricular capacitance (Figure 2B ), the vol- LV Volume (ml) LV Pressure (mm Hg)
The EDPVR is nonlinear. Stiffness is indexed by the change in pressure divided by the change in volume (dP/dV), varies with pressure. P/V, the ratio of end-diastolic pressure to volume, also varies with pressure. The myocardial stiffness constant, (dP/dV)/(P/V), is considered a valid measure of myocardial diastolic material properties. (B) One clinically useful index of diastolic properties is ventricular capacitance, which is the volume at a specified pressure such as V 30 , the volume at 30 mm Hg. Abbreviations as in Figure 1 .
Hemodynamics of Circulatory Support
following initiation of MCS. Both components of device effects will be discussed later. Importantly, the basic principles to be discussed apply across a wide range of conditions.
RA-TO-ARTERIAL CIRCULATORY SUPPORT. Extracorporeal venoarterial membrane oxygenation (ECMO), also referred to as extracorporeal life support, utilizes a pump with the capacity to assume responsibility for the entire cardiac output and a gas exchange unit for normalizing pCO 2 , pO 2 , and pH.
However, strictly on a hemodynamic basis, the use of this circuit configuration can cause significant increases in LV pre-load and, in some cases, pulmonary edema. This is illustrated in Figure 4A , which depicts These responses to ECMO can be modulated by secondary regulatory factors that influence either TPR or LV contractility. TPR can be reduced naturally by the baroreceptors, pharmacologically (e.g., nitroprusside), or mechanically (e.g., by intra-aortic balloon pumping). As illustrated in Figure 4B , a 50% reduction in TPR during ECMO markedly blunts the rise in LV EDP.
Short-term improvements in LV function can also modulate the rise in PCWP. LV function can be improved during ECMO due to increased central aortic pressure, the improved coronary perfusion, normalization of blood oxygen content (improved oxygen delivery to the myocardium), and normalization of acid-base and other metabolic abnormalities. Pharmacological enhancement of contractility (e.g., by
b-agonists or phosphodiesterase inhibitors) is also possible, but may not be beneficial in cardiogenic shock due to their independent effects to increase MVO 2 and potential effects on heart rate and arrhythmias. As illustrated in Figure 4B , a 50% increase in LV Ees during ECMO also blunts the primary rise in LV EDP. Although all forms of mechanical circulatory support return blood to the arterial system, they differ with respect to the site from which they draw blood. These differences underlie differences in their hemodynamic effects. Percutaneous (A) and durable ventricular devices (B) that take blood from the LV have similar physiology.
Extracorporeal membrane oxygenation (ECMO) withdraws blood from the right atrium or venous system and utilizes a blood gas exchange unit (C). Percutaneous devices can also achieve LA sourcing of blood (without need for a gas exchange unit) (D). LA ¼ left atrium/atrial; LV ¼ left ventricle/ventricular.
Burkhoff et al.
When secondary factors are insufficient to self- Another consideration for durable LV-to-arterial MCS is the difference in characteristics between axial and centrifugal flow pumps, typified by the HVAD and HeartMate II, respectively, the 2 pumps in most common use today. Some authors argue that the differences are significant, largely on the basis of theoretical considerations (14) . However, in a recent study in experimental heart failure in which these types of pumps were compared (20) , the authors concluded that there were no pronounced acute differences. This is consistent with our own recent clinical data showing no significant differences in overall hemodynamic effects of these 2 pumps (7).
Further work on this topic is needed because new pumps of both types are currently being introduced into the clinic. Burkhoff et al. As a first step towards that end, the theories and simulations described earlier led us to propose a means of evaluating the adequacy of MCS and medical therapy by simultaneous evaluation of central 
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